Remodeling dendritic spines for treatment of traumatic brain injury

被引:0
作者
Ye Xiong [1 ]
Asim Mahmood [1 ]
Michael Chopp [2 ,3 ]
机构
[1] Department of Neurosurgery, Henry Ford Hospital
[2] Department of Neurology, Henry Ford Hospital
[3] Department of Physics, Oakland University
关键词
traumatic brain injury; dendritic spines; synaptic plasticity; spinogenic agents; treatment; spine remodeling; memory; functional recovery;
D O I
暂无
中图分类号
R651.15 [];
学科分类号
1002 ; 100210 ;
摘要
Traumatic brain injury is an important global public health problem. Traumatic brain injury not only causes neural cell death, but also induces dendritic spine degeneration. Spared neurons from cell death in the injured brain may exhibit dendrite damage, dendritic spine degeneration, mature spine loss, synapse loss, and impairment of activity. Dendritic degeneration and synapse loss may significantly contribute to functional impairments and neurological disorders following traumatic brain injury. Normal function of the nervous system depends on maintenance of the functionally intact synaptic connections between the presynaptic and postsynaptic spines from neurons and their target cells. During synaptic plasticity, the numbers and shapes of dendritic spines undergo dynamic reorganization. Enlargement of spine heads and the formation and stabilization of new spines are associated with long-term potentiation, while spine shrinkage and retraction are associated with long-term depression. Consolidation of memory is associated with remodeling and growth of preexisting synapses and the formation of new synapses. To date,there is no effective treatment to prevent dendritic degeneration and synapse loss. This review outlines the current data related to treatments targeting dendritic spines that propose to enhance spine remodeling and improve functional recovery after traumatic brain injury. The mechanisms underlying proposed beneficial effects of therapy targeting dendritic spines remain elusive, possibly including blocking activation of Cofilin induced by beta amyloid, Ras activation, and inhibition of GSK-3 signaling pathway. Further understanding of the molecular and cellular mechanisms underlying synaptic degeneration/loss following traumatic brain injury will advance the understanding of the pathophysiology induced by traumatic brain injury and may lead to the development of novel treatments for traumatic brain injury.
引用
收藏
页码:1477 / 1480
页数:4
相关论文
共 50 条
  • [41] Treatment of depression following traumatic brain injury
    Alderfer, BS
    Arciniegas, DB
    Silver, JM
    JOURNAL OF HEAD TRAUMA REHABILITATION, 2005, 20 (06) : 544 - 562
  • [42] The use of antioxidants in the treatment of traumatic brain injury
    Venegoni, Whitney
    Shen, Qiuhua
    Thimmesch, Amanda R.
    Bell, Meredith
    Hiebert, John B.
    Pierce, Janet D.
    JOURNAL OF ADVANCED NURSING, 2017, 73 (06) : 1331 - 1338
  • [43] Peptidergic drugs for the treatment of traumatic brain injury
    Alvarez, X. Anton
    Figueroa, Jesus
    Muresanu, Dafin
    FUTURE NEUROLOGY, 2013, 8 (02) : 175 - 192
  • [44] Imatinib treatment reduces brain injury in a murine model of traumatic brain injury
    Su, Enming J.
    Fredriksson, Linda
    Kanzawa, Mia
    Moore, Shannon
    Folestad, Erika
    Stevenson, Tamara K.
    Nilsson, Ingrid
    Sashindranath, Maithili
    Schielke, Gerald P.
    Warnock, Mark
    Ragsdale, Margaret
    Mann, Kris
    Lawrence, Anna-Lisa E.
    Medcalf, Robert L.
    Eriksson, Ulf
    Murphy, Geoffrey G.
    Lawrence, Daniel A.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
  • [45] Ferroptosis and traumatic brain injury
    Geng, Zhiwen
    Guo, Zhiliang
    Guo, Ruibing
    Ye, Ruidong
    Zhu, Wusheng
    Yan, Bernard
    BRAIN RESEARCH BULLETIN, 2021, 172 : 212 - 219
  • [46] SUSTAINED EXPRESSION OF BRAIN-DERIVED NEUROTROPHIC FACTOR IS REQUIRED FOR MAINTENANCE OF DENDRITIC SPINES AND NORMAL BEHAVIOR
    Vigers, A. J.
    Amin, D. S.
    Talley-Farnham, T.
    Gorski, J. A.
    Xu, B.
    Jones, K. R.
    NEUROSCIENCE, 2012, 212 : 1 - 18
  • [47] Targeted treatment in severe traumatic brain injury in the age of precision medicine
    Anthony A. Figaji
    A. Graham Fieggen
    Ncedile Mankahla
    Nico Enslin
    Ursula K Rohlwink
    Child's Nervous System, 2017, 33 : 1651 - 1661
  • [48] Targeted treatment in severe traumatic brain injury in the age of precision medicine
    Figaji, Anthony A.
    Fieggen, A. Graham
    Mankahla, Ncedile
    Enslin, Nico
    Rohlwink, Ursula K.
    CHILDS NERVOUS SYSTEM, 2017, 33 (10) : 1651 - 1661
  • [49] Treatment of traumatic brain injury with thymosin β4 in rats Laboratory investigation
    Xiong, Ye
    Mahmood, Asim
    Meng, Yuling
    Zhang, Yanlu
    Zhang, Zheng Gang
    Morris, Daniel C.
    Chopp, Michael
    JOURNAL OF NEUROSURGERY, 2011, 114 (01) : 102 - 115
  • [50] Traumatic brain injury—the effects of patient age on treatment intensity and mortality
    Ola Skaansar
    Cathrine Tverdal
    Pål Andre Rønning
    Karoline Skogen
    Tor Brommeland
    Olav Røise
    Mads Aarhus
    Nada Andelic
    Eirik Helseth
    BMC Neurology, 20